246 related articles for article (PubMed ID: 28682649)
1. Targeting Ras signaling in AML: RALB is a small GTPase with big potential.
Pomeroy EJ; Eckfeldt CE
Small GTPases; 2020 Jan; 11(1):39-44. PubMed ID: 28682649
[TBL] [Abstract][Full Text] [Related]
2. RALB provides critical survival signals downstream of Ras in acute myeloid leukemia.
Eckfeldt CE; Pomeroy EJ; Lee RD; Hazen KS; Lee LA; Moriarity BS; Largaespada DA
Oncotarget; 2016 Oct; 7(40):65147-65156. PubMed ID: 27556501
[TBL] [Abstract][Full Text] [Related]
3. Ras oncogene-independent activation of RALB signaling is a targetable mechanism of escape from NRAS(V12) oncogene addiction in acute myeloid leukemia.
Pomeroy EJ; Lee LA; Lee RDW; Schirm DK; Temiz NA; Ma J; Gruber TA; Diaz-Flores E; Moriarity BS; Downing JR; Shannon KM; Largaespada DA; Eckfeldt CE
Oncogene; 2017 Jun; 36(23):3263-3273. PubMed ID: 27991934
[TBL] [Abstract][Full Text] [Related]
4. RalB directly triggers invasion downstream Ras by mobilizing the Wave complex.
Zago G; Veith I; Singh MK; Fuhrmann L; De Beco S; Remorino A; Takaoka S; Palmeri M; Berger F; Brandon N; El Marjou A; Vincent-Salomon A; Camonis J; Coppey M; Parrini MC
Elife; 2018 Oct; 7():. PubMed ID: 30320548
[TBL] [Abstract][Full Text] [Related]
5. RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer.
Yan C; Theodorescu D
Pharmacol Rev; 2018 Jan; 70(1):1-11. PubMed ID: 29196555
[TBL] [Abstract][Full Text] [Related]
6. The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer.
Guin S; Theodorescu D
Acta Pharmacol Sin; 2015 Mar; 36(3):291-7. PubMed ID: 25557115
[TBL] [Abstract][Full Text] [Related]
7. Ras-related small GTPases RalA and RalB regulate cellular survival after ionizing radiation.
Kidd AR; Snider JL; Martin TD; Graboski SF; Der CJ; Cox AD
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):205-12. PubMed ID: 20619549
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Ral GTPases Using a Stapled Peptide Approach.
Thomas JC; Cooper JM; Clayton NS; Wang C; White MA; Abell C; Owen D; Mott HR
J Biol Chem; 2016 Aug; 291(35):18310-25. PubMed ID: 27334922
[TBL] [Abstract][Full Text] [Related]
9. Ral activation promotes melanomagenesis.
Zipfel PA; Brady DC; Kashatus DF; Ancrile BD; Tyler DS; Counter CM
Oncogene; 2010 Aug; 29(34):4859-64. PubMed ID: 20562921
[TBL] [Abstract][Full Text] [Related]
10. Differential involvement of RalA and RalB in colorectal cancer.
Martin TD; Der CJ
Small GTPases; 2012; 3(2):126-30. PubMed ID: 22790202
[TBL] [Abstract][Full Text] [Related]
11. Divergent roles of CAAX motif-signaled posttranslational modifications in the regulation and subcellular localization of Ral GTPases.
Gentry LR; Nishimura A; Cox AD; Martin TD; Tsygankov D; Nishida M; Elston TC; Der CJ
J Biol Chem; 2015 Sep; 290(37):22851-61. PubMed ID: 26216878
[TBL] [Abstract][Full Text] [Related]
12. The RAL signaling network: Cancer and beyond.
Apken LH; Oeckinghaus A
Int Rev Cell Mol Biol; 2021; 361():21-105. PubMed ID: 34074494
[TBL] [Abstract][Full Text] [Related]
13. Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.
McMahon CM; Ferng T; Canaani J; Wang ES; Morrissette JJD; Eastburn DJ; Pellegrino M; Durruthy-Durruthy R; Watt CD; Asthana S; Lasater EA; DeFilippis R; Peretz CAC; McGary LHF; Deihimi S; Logan AC; Luger SM; Shah NP; Carroll M; Smith CC; Perl AE
Cancer Discov; 2019 Aug; 9(8):1050-1063. PubMed ID: 31088841
[TBL] [Abstract][Full Text] [Related]
14. Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation.
Tecleab A; Zhang X; Sebti SM
J Biol Chem; 2014 Nov; 289(45):31296-309. PubMed ID: 25210032
[TBL] [Abstract][Full Text] [Related]
15. The RalB small GTPase mediates formation of invadopodia through a GTPase-activating protein-independent function of the RalBP1/RLIP76 effector.
Neel NF; Rossman KL; Martin TD; Hayes TK; Yeh JJ; Der CJ
Mol Cell Biol; 2012 Apr; 32(8):1374-86. PubMed ID: 22331470
[TBL] [Abstract][Full Text] [Related]
16. Characterization of RalB-Sec5-TBK1 function in human oncogenesis.
Chien Y; White MA
Methods Enzymol; 2008; 438():321-9. PubMed ID: 18413258
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic NRAS Primes Primary Acute Myeloid Leukemia Cells for Differentiation.
Brendel C; Teichler S; Millahn A; Stiewe T; Krause M; Stabla K; Ross P; Huynh M; Illmer T; Mernberger M; Barckhausen C; Neubauer A
PLoS One; 2015; 10(4):e0123181. PubMed ID: 25901794
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation by protein kinase Cα regulates RalB small GTPase protein activation, subcellular localization, and effector utilization.
Martin TD; Mitin N; Cox AD; Yeh JJ; Der CJ
J Biol Chem; 2012 Apr; 287(18):14827-36. PubMed ID: 22393054
[TBL] [Abstract][Full Text] [Related]
19. Discovery and characterization of small molecules that target the GTPase Ral.
Yan C; Liu D; Li L; Wempe MF; Guin S; Khanna M; Meier J; Hoffman B; Owens C; Wysoczynski CL; Nitz MD; Knabe WE; Ahmed M; Brautigan DL; Paschal BM; Schwartz MA; Jones DN; Ross D; Meroueh SO; Theodorescu D
Nature; 2014 Nov; 515(7527):443-7. PubMed ID: 25219851
[TBL] [Abstract][Full Text] [Related]
20. RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia.
Gu C; Feng M; Yin Z; Luo X; Yang J; Li Y; Li T; Wang R; Fei J
Oncotarget; 2016 Apr; 7(15):20561-73. PubMed ID: 26967392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]